Jump to: navigation, search

B-cell acute lymphoblastic leukemia - historical

790 bytes added, 23:39, 28 December 2018
L-Asparaginase, Vincristine, Prednisone {{#subobject:d039d8|Regimen=1}}
|[[B-cell_acute_lymphoblastic_leukemia#Daunorubicin.2C_L-Asparaginase.2C_Vincristine.2C_Prednisone|Daunorubicin, L-Asparaginase, Vincristine, Prednisone]]
|style="background-color:#ffffbf"|Seems not superior
|[ Tubergen et al. 1993 (CCG-105)]
|style="background-color:#1a9851"|Phase III (C)
|[[B-cell_acute_lymphoblastic_leukemia#Daunorubicin.2C_L-Asparaginase.2C_Vincristine.2C_Prednisone|Daunorubicin, L-Asparaginase, Vincristine, Prednisone]]
|style="background-color:#d3d3d3"|Not reported
|[ Bostrom et al. 2003 (CCG-1922)]
# '''DCLSG ALL V:''' van der Does-van den Berg A, van Wering ER, Suciu S, Solbu G, van 't Veer MB, Rammeloo JA, de Koning J, van Zanen GE. Effectiveness of rubidomycin in induction therapy with vincristine, prednisone, and L-asparaginase for standard risk childhood acute lymphocytic leukemia: results of a Dutch phase III study (ALL V); A report on behalf of the Dutch Childhood Leukemia Study Group (DCLSG). Am J Pediatr Hematol Oncol. 1989 Summer;11(2):125-33. [ PubMed]
# '''MRC UKALL VIII:''' Eden OB, Lilleyman JS, Richards S, Shaw MP, Peto J. Results of Medical Research Council Childhood Leukaemia Trial UKALL VIII (report to the Medical Research Council on behalf of the Working Party on Leukaemia in Childhood). Br J Haematol. 1991 Jun;78(2):187-96. [ link to original article] [ PubMed]
# '''CCG-105:''' Tubergen DG, Gilchrist GS, O'Brien RT, Coccia PF, Sather HN, Waskerwitz MJ, Hammond GD. Improved outcome with delayed intensification for children with acute lymphoblastic leukemia and intermediate presenting features: a Childrens Cancer Group phase III trial. J Clin Oncol. 1993 Mar;11(3):527-37. [ link to original article] [ PubMed]
# '''CCG-1922:''' Bostrom BC, Sensel MR, Sather HN, Gaynon PS, La MK, Johnston K, Erdmann GR, Gold S, Heerema NA, Hutchinson RJ, Provisor AJ, Trigg ME; Children's Cancer Group. Dexamethasone versus prednisone and daily oral versus weekly intravenous mercaptopurine for patients with standard-risk acute lymphoblastic leukemia: a report from the Children's Cancer Group. Blood. 2003 May 15;101(10):3809-17. Epub 2003 Jan 16. [ link to original article] [ PubMed]
LookupUsers, editors, emailconfirmed

Navigation menu